(PharmaNewsWire.Com, September 19, 2019 ) According to the new market research report Coagulation Analyzer Market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021. The coagulation analyzers market is dominated by few major players, with the top 3 players accounting for a majority of the market share. Prominent players in the coagulation analyzers market include Sysmex Corporation (Japan), Siemens Healthcare (Germany), Roche Diagnostics (Switzerland), Instrumentation Laboratory Werfen Group (U.S.), Helena Laboratories (U.S.), Nihon Kohden Corporation (Nihon Kohden) (Japan), Beckman Coulter, Inc. (U.S.), International Technidyne Corporation (U.S.), Diagnostica Stago, Inc. (France), Alere, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.), among others.
Sysmex Corporation was the leader in the coagulation analyzers market in 2014. Sysmex is an integrated supplier of instruments, reagents, and services in the field of diagnostics. The company continues to be an undisputed global leader in the hemostasis field. The company operates its hemostasis business through three product segments, namely, instruments, reagents, and maintenance services. Geographically, Sysmex Group operates through 44 companies in 29 countries across North America, Latin America, Europe, and Asia-Pacific. The company’s wide range of product offerings, coupled with its wide geographic presence, enables it to maintain its leading position in the global coagulation analyzers market. Furthermore, the company focuses on the development of innovative products, geographic expansions in emerging markets, and strategic acquisitions as its key business strategies to maintain its leadership position in the global coagulation analyzers market.
In the coagulation analyzers market, leading players are adopting the strategies of new product development, geographic expansion, agreements, acquisitions, and joint ventures. Market players adopted these strategies to access new technologies, expand their product portfolios, enter into growing markets, and increase their market shares. In addition to top market players, companies such as Sysmex Corporation (Japan), Siemens Healthcare (Germany), and Roche Diagnostics (Switzerland) are primarily focusing on launching new hemostasis analyzers and reagents to widen their product offerings.
Major strategic developments are taking place in the coagulation analyzers market, which exhibits high-growth potential in the near future. Dominant market players such as Sysmex Corporation (Japan) and Siemens Healthcare (Germany) introduced several technologically advanced hemostasis analyzers in order to keep pace with industry trends.
Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 newsletter@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
